Connect with us
[the_ad id="89560"]

Health

‘Shocking cover-up’: DOJ lawyers committed fraud in vaccine injury case, CHD attorney alleges in motion

Published

24 minute read

From LifeSiteNews

By Brenda Baletti, Ph.D., The Defender

“The evidence submitted in support of the motion clearly shows that attorneys from the Department of Justice concealed and misrepresented highly relevant information from the special masters in the Vaccine Injury Compensation Program and the judges in the courts”

Rolf Hazlehurst, a Children’s Health Defense (CHD) staff attorney and father of a son with autism, filed a motion in federal court on April 2 alleging lawyers representing the U.S. Department of Health and Human Services (HHS) fraudulently concealed evidence that vaccines can cause autism.

In a motion filed in the U.S. Court of Federal Claims, Hazlehurst alleged that U.S. Department of Justice (DOJ) lawyers who represented HHS in vaccine injury cases repeatedly defrauded the judicial system – from the National Vaccine Injury Compensation Program (NVICP) to the U.S. Supreme Court.

That fraud led to thousands of families of vaccine-injured children being denied the right to compensation and the right to have their cases heard, according to the motion.

“This motion makes very serious and well-substantiated allegations of a massive scheme of fraud on the courts,” said Kim Mack Rosenberg, CHD general counsel who also is of counsel to Hazlehurst in the federal case.

“The evidence submitted in support of the motion clearly shows that attorneys from the Department of Justice concealed and misrepresented highly relevant information from the special masters in the Vaccine Injury Compensation Program and the judges in the courts,” Mack Rosenberg told The Defender.

Hazlehurst’s son Yates regressed into autism after being vaccinated as an infant. In the early 2000s, his family and thousands of others filed cases seeking compensation for vaccine-induced autism through the NVICP.

Unbeknownst at the time to the petitioners and the NVICP special masters, the DOJ’s star expert medical witness, Dr. Andrew Zimmerman informed DOJ attorneys during the ongoing omnibus proceedings that he had reversed his original opinion and determined that vaccines can and do cause autism in some cases.

In what Hazlehurst alleges was “a shocking cover-up,” instead of allowing Zimmerman to share his revised opinion, the DOJ attorneys relieved Zimmerman of his duties as a witness.

However, they continued to use excerpts from his unamended written opinion to make their case that vaccines did not cause autism – misrepresenting his position and committing “fraud on the court.”

According to the motion, the DOJ’s first act of fraud snowballed into a scheme of deception with far-reaching implications in which DOJ attorneys repeatedly misrepresented Zimmerman’s opinion and concealed other evidence that emerged during the test case hearings in the OAP in subsequent cases before multiple courts.

“As a result, thousands of cases in the Omnibus Autism Proceeding were denied compensation and the impact beyond the OAP is enormous,” Mack Rosenberg said. “This fraud affected the Vaccine Injury Compensation Program – especially the Omnibus Autism Proceeding – the Court of Federal Claims, the Court of Appeals for the Federal Circuit and even the U.S. Supreme Court.”

Hazlehurst said he is “asking the court to give this motion the serious attention it deserves.” He added, “At a minimum, the court should allow discovery and hold a hearing on this motion.”

Overturning a ruling due to fraud on the court is an extraordinary remedy reserved for extraordinary cases but according to Hazlehurst, “This motion we filed shows that this indeed is an extraordinary case.”

The DOJ has until April 30 to respond to the motion.

CHD CEO Mary Holland told The Defender, “Vaccines most definitely do cause autism, and the government has been lying about this reality for decades.”

Holland added:

With others, I published a law review article in 2011 showing that the government absolutely knew that vaccines cause autism – and yet they have covered it up and lied about it since the inception of the Vaccine Injury Compensation Program.

How many hundreds of thousands of children and families would have been spared the heartaches and crushing financial burdens of autism had the government come clean?

‘Exceptionally difficult’ to obtain compensation through NVICP

In the late 1980s, a substantial number of lawsuits for vaccine injuries related to Wyeth’s (now Pfizer) DPT vaccine, combined with “grossly insufficient compensation” for victims of vaccine injury, threatened the vaccine program’s viability.

In response, Congress passed the National Childhood Vaccine Injury Act of 1986, which established the “vaccine court.” The law gave the pharmaceutical industry broad protection from liability and proposed to compensate vaccine-injured children through the new NVICP.

The NVICP originally was designed to be a “swift, flexible, and less adversarial alternative to the often costly and lengthy civil arena of traditional tort litigation.”

To receive compensation, parents file a claim with the program.

The Court of Federal Claims (which oversees the program) appoints “special masters” – typically lawyers who previously represented the U.S. government – to manage and decide the individual claims. Attorneys may represent the petitioners, and the DOJ represents HHS.

NVICP proceedings are more informal than a typical courtroom. Unlike regular court proceedings, petitioners in the “vaccine court” have no right to discovery.

If a petitioner files a claim for a vaccine covered under the program and listed on the Vaccine Injury Table – the list of known vaccine side effects associated with certain vaccines within set time frames – it is presumed that a vaccine caused the petitioner’s injury and the petitioner is eligible for compensation without proof of causation.

However, if a petitioner experiences an “off-table injury” – an injury not listed on the table or that didn’t happen in the recognized injury time frame – the petitioner must prove by “a preponderance of evidence” that the vaccine caused the injury. Evidence includes medical records and expert witness testimony.

Claims must be filed within three years of the first symptom or two years of death.

Petitioners must provide a medical theory of the cause, a sequence of cause and effect, and show a temporal relationship between vaccine and injury.

However, the NVICP does not specify the required volume and type of evidence, so meeting the “preponderance of evidence” standard is largely at the discretion of the special master.

Petitioners can appeal NVICP cases to the Court of Federal Claims, the Court of Appeals for the Federal Circuit and ultimately to the U.S. Supreme Court.

It is “exceptionally difficult” to obtain compensation within the NVICP, Hazlehurst told The Defender. The proceedings are often turned into drawn-out, contentious expert battles and the backlog of cases is substantial.

The Vaccine Act of 1986 is unjust for petitioners, Hazlehurst alleges. And that injustice reached its zenith with the OAP, when the DOJ perpetrated fraud right under the noses of the special masters, signaling the beginning of the fraud on the courts that continues to this day.

Hazlehurst told The Defender he hopes his motion will shed light on the damage inflicted by this law and that it will ultimately help end the autism epidemic.

“The Vaccine Act of 1986 is one of the fundamental causes of the autism epidemic,” Hazlehurst said. “Understanding why this is true, and how the United States Department of Justice perpetrated fraud upon the courts, including the Supreme Court of the United States, is the key to ending the autism epidemic.”

A short history of the autism omnibus proceedings

By 2002, to address a “massive influx” of petitions alleging vaccine-induced autism, the Office of Special Masters combined over 5,000 claims into the OAP to determine whether vaccines cause autism and if so, under what conditions.

Initially, the NVICP planned to investigate causation issues and apply those general findings to individual cases. However, the program changed its strategy and instead selected six “test cases” by which it would examine the evidence for injuries caused by the measles mumps rubella (MMR) vaccine, thimerosal-containing vaccines (TCV), or a combination of both.

Then it would apply the findings of the test cases to other similar cases.

In doing so, Hazlehurst alleges, the court conflated general causation evidence with specific causation evidence from a few cases, without allowing for rules of discovery or evidence that would apply in an actual court.

This, Hazlehurst said, “was a recipe for disaster” as each test case was then used to determine the outcome for the remaining 5,000 cases.

Three cases – Cedillo v. HHSHazlehurst v. HHS, and Poling v. HHS – are at the center of the alleged fraud by the DOJ.

Fraud #1: the Zimmerman testimony

Hearings for the first OAP test case, Cedillo v. HHS, began in 2007. Zimmerman had worked with the DOJ to prepare an expert report on behalf of HHS finding that Michelle Cedillo’s autism had likely not been caused by the MMR vaccine.

Zimmerman later wrote in a 2018 affidavit that he attended the Cedillo hearing and listened to the testimony of Dr. Marcel Kinsbourne, another world-renowned expert in pediatric neurology.

On that basis, Zimmerman stated, he decided to clarify his written expert opinion about Michelle Cedillo, concerned it would be taken out of context.

Zimmerman spoke with DOJ attorneys to clarify that his expert opinion in the Cedillo case “was not intended to be a blanket statement as to all children and all medical science,” according to the 2018 affidavit.

He specified that advances in science, medicine and his own clinical research had led him to believe there were exceptions in which vaccinations could cause autism.

He also referred the attorneys to a paper he published with colleagues in 2006, the Poling paper, describing the case of an unidentified child who suffered regressive autism following vaccine adverse reactions. The paper suggested a possible association between mitochondrial dysfunction, vaccinations and regressive autism.

After communicating this evidence to DOJ attorneys, the DOJ dismissed Zimmerman as a witness but continued to use his written opinion as general causation evidence.

The DOJ was also allowed to use that report, submitted in one test case, as general causation evidence in other test cases.

None of the petitioners in the test cases could cross-examine Zimmerman, because he was no longer a witness. This was only possible because the federal rules of evidence do not apply in NVICP proceedings.

Yates’ case, Hazlehurst v. HHS, was the second test case in the OAP. His treating neurologist, Dr. Jean-Ronel Corbier testified Yates’ autism was likely caused by a genetic predisposition combined with an environmental insult in the form of vaccinations administered when Yates was ill. (Yates was a patient of Zimmerman in 2002.)

Corbier’s theory of causation in Yates was similar to the theory developed by Zimmerman in the Poling paper and shared with DOJ attorneys.

Yet, despite knowing Zimmerman had concluded that in a subset of children like Yates, vaccines can cause autism, the DOJ “intentionally and fraudulently” misrepresented Zimmerman’s expert testimony in its closing statements in Yates’ case, Hazlehurst alleges.

DOJ attorneys selectively quoted Zimmerman’s expert report from the Cedillo case, telling the court that Zimmerman found there was “no sound evidence to support a causative relationship with exposure to both or either MMR and/or mercury,” when Zimmerman had explicitly told the DOJ that his opinion was the opposite, according to the affidavit.

Fraud #2: the Hannah Poling case

Three weeks after closing arguments in Yates’ case, the DOJ quietly conceded Hannah Poling’s case, which was on the verge of becoming the fourth test case.

Hannah regressed into autism over several months after being vaccinated against nine diseases at one doctor’s visit.

In 2003, Poling’s father, Jon, a physician and trained neurologist, and mother, Terry, an attorney and nurse, filed an autism petition against HHS under the NVICP for their daughter’s injuries.

Jon Poling was a co-author of the 2006 paper with Zimmerman that analyzed an unnamed child, later revealed as Hannah Poling, who had a mitochondrial disorder – a condition with which Yates was later diagnosed.

In 2007, just three weeks after the lead DOJ attorney misrepresented Zimmerman’s opinion during the hearing in Hazlehurst, the same DOJ attorney submitted a report to the special masters conceding that in the case of Poling v. HHS, Hannah’s “regressive encephalopathy with features of autism spectrum disorder” (i.e., regressive autism) was caused by a vaccine injury, based upon a preponderance of the evidence standard.

This was the same neurological diagnosis Zimmerman had made for Yates in 2002.

According to court documents, if HHS had not conceded Poling, Poling v. HHS would have been designated as a test case. However, because the DOJ conceded the case, it was taken out of the omnibus and the DOJ had the case records sealed – although they were later leaked to the press and published in the Huffington Post in 2008.

In March 2008, Hannah’s parents moved to make the proceedings transparent and available to the public, but the DOJ opposed the motion and the NVICP deferred a ruling on the motion for 60 days.

During those 60 days, the DOJ filed amendments to its report conceding the Poling case. It retroactively changed the basis for compensation to say that Hannah had a “table injury.”

This meant that instead of conceding that the petitioners had proven with a preponderance of evidence that the vaccines caused her autism, they said she had a presumptive injury on the vaccine table, in which causation is presumed.

By conceding the Poling case, opposing the parents’ motion for complete transparency and changing the basis for compensation, the DOJ was able to conceal fraud and critical material evidence of how vaccines cause autism, according to Hazlehurst.

Fraud #3: appellate courts and the U.S. Supreme Court

On Feb. 12, 2009, the special masters denied compensation in the first three cases. They found the petitioners failed to establish causation between MMR or TCV vaccines and autism.

In Hazlehurst’s case, the NVICP explicitly relied on the portion of Zimmerman’s expert report that DOJ attorneys misrepresented.

The Hazlehursts appealed to the Court of Federal Claims and the Court of Appeals for the Federal Circuit, both of which upheld the special master’s decision – by relying on Zimmerman’s misrepresented opinion and knowingly fraudulent statements made by a DOJ attorney, according to Hazlehurst.

Those prior decisions directly influenced the U.S. Supreme Court’s decision in the Bruesewitz v. Wyeth.

In that case, Wyeth, now Pfizer, argued that a decision favoring the Bruesewitz family – who was attempting to sue the company for their daughter’s vaccine injury – would lead to a “flood of frivolous lawsuits,” including by the families from the omnibus.

Amicus briefs from the American Academy of Pediatrics, GlaxoSmithKline, Merck and Sanofi Pasteur on behalf of Wyeth relied on Hazlehurst v. HHS and other OAP decisions that were based on the misrepresentation of Zimmerman’s testimony that there was “no scientific basis” that vaccines cause autism.

The Supreme Court ruled that the National Childhood Vaccine Injury Act, and the NVICP it created, preempt all design-defect claims against vaccine manufacturers by individuals seeking compensation for injury or death.

In oral arguments and in their written opinions, the justices explicitly cited the portions of the amicus briefs citing Hazlehurst v. HHS and other OAP rulings that relied on the DOJ misrepresentations in their rulings.

Since that ruling, the special masters have continued to rely on the DOJ’s fraudulent claims to deny compensation to families filing complaints in the NVICP.

Robert F. Kennedy Jr., CHD chairman on leave, and Hazlehurst in September 2018 filed a complaint with the DOJ Office of Inspector General outlining what they then knew about the DOJ’s fraud during the OAP.

The DOJ Office of Professional Misconduct investigated and responded in a June 2019 letter that it found no wrongdoing.

In that letter, however, the Office of Professional Responsibility conceded the DOJ had in fact kept Zimmerman’s testimony while dismissing him as a witness in order to avoid creating the appearance that he had changed his opinion and to prevent the petitioners from cross-examining him, according to Hazlehurst.

The ‘fraud on the court’ doctrine 

It has taken 17 years, Hazlehurst said, since the DOJ’s first alleged act of fraud upon the court, for him to gather all of the admissible evidence necessary to “connect the dots and reveal the DOJ’s web of deceit” to make this claim under the “fraud on the court” doctrine.

Under this doctrine, codified as Rule 60(d)(3) in the rules of the Court of Federal Claims, there is no time limit for the court to overturn a judgment made on the basis of fraud on the court.

The petitioner must demonstrate that there was fraud, intent to defraud and that the fraud affected more than one instance of litigation – putting the integrity of the judicial process at stake.

Hazlehurst alleges DOJ attorneys committed fraud by knowingly making false statements and offering evidence they knew to be false and that they did not take remedial action to disclose information they knew to be false and misleading to the court.

The special masters themselves have an obligation to consider all relevant evidence, but didn’t, in this case, Hazlehurst said. Instead, they ignored the contradictions in Zimmerman’s opinions and ignored the Poling evidence.

This is particularly problematic for NVICP cases, where petitioners can’t conduct meaningful discovery or cross-examination and the special masters’ oversight is the only meaningful safeguard to prevent the DOJ’s abuse of power, according to Hazlehurst.

“There is nothing fair about a government proceeding where the government controls the admissibility of evidence,” he said.

Hazlehurst said that by forcing people injured by vaccines into an administrative program, petitioners are deprived of the basic constitutional rights to due process and equal protection under the law. “It should be declared unconstitutional,” he said.

This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.

Health

DMSO Heals the Eyes and Transforms Ophthalmology

Published on

DMSO’s unique therapeutic properties reveal the unifying thread between many different “incurable” eye diseases.

Story at a Glance:

• DMSO is an “umbrella remedy” capable of treating a wide range of challenging ailments due to its combination of therapeutic properties (e.g., reducing inflammation, improving circulation, and reviving dying cells).

• DMSO has a unique affinity for the eyes, resulting in it (often spontaneously) treating a wide range of visual disorders that frequently cannot be treated with conventional therapeutic options.

• DMSO’s ability to restore circulation, revive dying cells, and stabilize misfolded proteins allows it to treat a variety of retinal diseases (e.g., macular degeneration, diabetic retinopathy or retinitis pigmentosa—in some cases reversing permanent blindness), eliminate visual obstructions (e.g., floaters and cataracts), reverse glaucoma or Fuchs’ dystrophy, and restore normal focus (frequently eliminating the need for glasses).

• DMSO’s anti-inflammatory and antimicrobial properties allow it to treat dry eyes, inflammatory diseases around the eye (e.g., blepharitis, styes, and psoriasis) or within the eye (e.g., iritis, uveitis, conjunctivitis, keratitis), along with bacterial, fungal, parasitic, or viral eye infections such as shingles.

•DMSO’s healing properties also allow it to heal a variety of eye injuries (including severe ones which would otherwise require eye removal), skin issues around the eye (e.g., burns, skin tags, and under-eye bags), and eliminate eye muscle spasms.

•This article will review the extensive data demonstrating DMSO’s efficacy for eye diseases, along with an examination of the most common protocols used for them and other natural approaches that also aid in the treatment of common eye disorders.

Since 2024, I have been working diligently to present the extensive data that DMSO is a remarkable therapeutic that is uniquely suited to treat many highly challenging medical conditions due to its counteracting many root causes of disease (whereas, in contrast, vaccines cause a myriad of health issues by inducing those key drivers of illness). From this, I’ve compiled a series of articles synthesizing thousands of studies that have shown DMSO effectively treats:

  • Strokes, paralysis, a wide range of neurological disorders (e.g., Down Syndrome and dementia), and many circulatory disorders (e.g., Raynaud’s, varicose veins, hemorrhoids), which I discussed here.
  • A wide range of tissue injuries, such as sprains, concussions, burns, surgical incisions, and spinal cord injuries (discussed here).
  • Chronic pain (e.g., from a bad disc, bursitis, arthritis, or complex regional pain syndrome), which I discussed here.
  • A wide range of autoimmune, protein, and contractile disorders, such as scleroderma, amyloidosis, and interstitial cystitis (discussed here).
  • A variety of head conditions, such as tinnitus, vision loss, dental problems, and sinusitis (discussed here).
  • A wide range of internal organ diseases (discussed here).
  • Many different respiratory disorders, including asthma and COPD (discussed here)
  • Many different gastrointestinal disorders, such as bowel inflammation, cirrhosis, and pancreatitis (discussed here)
  • A wide range of skin conditions, such as burns, varicose veins, acne, hair loss, ulcers, skin cancer, and many autoimmune dermatologic diseases (discussed here).
  • Many challenging infectious conditions, including chronic bacterial infections, herpes, and shingles (discussed here).
  • Many aspects of cancer (e.g., many of cancer’s debilitating symptoms, making cancer treatments more potent, greatly reducing the toxicity of conventional therapies, and turning cancer cells back into normal cells), which I discussed here.

Since the evidence in those articles (along with one on how DMSO can be synergistically combined with pharmaceuticals and another on how DMSO combines with natural therapies) made a compelling case for the use of DMSO, many readers opted to start using it. Many of them, in turn, had remarkable improvements which caused them to recommend DMSO to their peers, and because of all those successes, a widespread interest in DMSO has now emerged.

On one hand, this has been quite surprising to me as the information I publicized has been widely available for decades, but (possibly due to it being impossible to profit off DMSO because of how little it costs) most of the people exposed to this series were not even aware this therapy existed, let alone what DMSO could do. Conversely, the groundswell of interest is not surprising as it’s nearly identical to what happened when DMSO was first discovered in the 1960s and it rapidly became the most popular drug in America—particularly since relatively minimal progress has been made on most of the “incurable” conditions it cured back then. Consider for example this 1980 segment 60 minutes created, which showed the remarkable results generated from the therapeutic use of DMSO and more importantly, the exact same stonewalling and suppression of DMSO from the FDA that we saw throughout COVID-19:

User DMSO Reports

Because of DMSO’s high degree of efficacy, the moment I began the series, I started being flooded with testimonials from readers of the remarkable improvements DMSO had created for them. Before long, I realized I was in a similar situation to what I’d been in throughout COVID-19.

I have long believed one of the core strategies the ruling class always follows is to establish rigid hierarchical systems that have dominion over critical facets of society and then buy out the top of the pyramid, as that provides a relatively low-cost way to control the entire society. In the case of medicine, this has translated to having pharmaceutical compliant individuals (through industry funding and media complicity) be anointed as experts who reinforce the profitable orthodoxy alongside having medical journals only publish things which cater to the existing vested interests.

Because of this, things that are “controversial” (threatening vested interests) are rarely published in a “credible” medium, and as a result, anyone who tries to advocate for them is not listened to; instead, they are chastised for endorsing “unproven” and unscientific beliefs.

When the COVID vaccines hit the market, I had expected they would cause a significant number of chronic issues that would take years to be recognized—so I was quite shocked to be immediately flooded with reports across the country of severe reactions of all types from the vaccine. Because of this, I felt I needed to log them as I knew injuries like these would never get published in medical journals and I wanted to have some type of proof that vaccine injuries were real, so in the future I could present accurate information to skeptical parties. I hence spent an inordinate amount of time interviewing those involved and compiling all of them and after unexpectedly gaining a Substack audience, I published that log, and it went viral because my small sample accurately represented the pattern of vaccine injuries everyone was seeing around them and because more than a year into the COVID vaccine rollout, no one had done anything similar—despite the massive demand for this type of information.

In the process of doing that, I had also received a lot of reports of individuals who appeared to be being injured by COVID vaccine shedding—despite this being “impossible” based on the purported design of the vaccines. As the reports, like those for the COVID-19 vaccine injuries, were consistent in character (and like the vaccines many affected by shedding were understandably desperate for information on the topic) I decided to spend a year compiling thousands of those reports as I knew there would never be a journal willing to touch the subject. Following this, I then produced a synthesis of that data which showed there were clear repeating patterns to mRNA shedding and provided the critical mechanisms to explain this seemingly inexplicable phenomenon. That, in turn, was an inordinate amount of work to do, but succeeded and made many realize shedding is a real risk of the mRNA technology—something which will be critical for opposing future attempts to inject the population with experimental gene therapies.

In the case of DMSO, as I started receiving all of these reports (at a time when I had essentially finished the shedding project), I realized that I had access to a unique dataset that had not previously been available. More importantly, because there were so many different things that DMSO could treat, a dataset like this would likely be the only place much of that therapeutic data could ever be compiled (as no one would ever get around to conducting studies on many of those uses—particularly since the current academic publishing climate is much more hostile to publishing unorthodox research now than it was fifty years ago).

So, over the last 13 months, one of my primary projects has been to compile all the reports I’ve received (which I did in the comments here), and I presently have 4,721 comments—of which I think roughly 3,000 are unique stories of therapeutic benefit people have experienced. In turn, my plan is to eventually compile and synthesize all of that, but as doing that will take at least a month, I’ve held off until the end of the series (so I wouldn’t have to redo it with new data that was subsequently received).
Note: my general sense from all the testimonials I’ve received is that between 80-90% of users have a positive response to using DMSO (which is frankly extraordinary), with lower rates (50%) being seen for certain issues which are harder to correctly treat with DMSO, and give or take 0% success rates being seen for issues DMSO is not thought to treat (suggesting the sample I’m observing is representative of real life data).

Within those comments, while most of the reports I’ve received are consistent with what DMSO is recognized to do (e.g., rapidly eliminating debilitating pain that nothing else had worked on), some were quite extraordinary and not what I’d expected to come across. For example, after I learned a 75 year old reader who’d been blind since birth had regained their sight after using DMSO to treat a sinus issue, I realized his story needed to be shared:

Note: as fate had it, Murray lived about 3 hours away from Rebecca Cunningham, the Texas-based documentary film maker who cured her neighbor’s terminal COPD with nebulized DMSO, after which millions saw Dan’s COPD story.1,2 As DMSO changed her life, she is currently collecting other DMSO testimonials on her Rumble channel and kindly agreed to travel to Murray to film this. If you have a story to share and are ever passing through Wimberley or visiting the hill country in Texas, please reach out to her.

In compiling these reports, I was struck by how many were for the eyes, by how well DMSO worked across an extensive range of eye conditions, and by the fact that, in the majority of cases, it provided better results than could be expected from existing ophthalmology options.

Note: the only well-recognized ophthalmologic conditions I did not receive reports on were amblyopia, strabismus, diabetic retinopathy, keratitis, optic neuritis, retinal detachment, retinopathy of prematurity, chalazions, central retinal vein occlusion (although a reader’s branched retinal vein occlusion responded to DMSO), and eye cancers—many of which, as I will show in this article, existing data sources suggest do respond to DMSO.

Later, while translating the discoveries of the German community, I learned their data matched that of the readers here:

One of the first new adopters of DMSO (circa 2012), began successfully using highly diluted DMSO for eye treatments in his practice. This led to a network of practitioners using DMSO for eye health, accumulating substantial experience, and, in many cases, treating eye issues where the cause could not be determined.

In general, there are a surprising number of successful reports using DMSO eye drops for a wide variety of eye symptoms and diseases. So many, in fact, that I now consider the DMSO eye solution an exceptional “eye care.”

Many users (especially those with heavy screen time) apply DMSO preventively to maintain eye freshness, improve tear quality, and reduce night glare. Positive effects, including improved vision, better tear film, fresher eyes, and reduced night glare, are often reported after the first few applications, enhancing overall eye comfort and function—including in people whom ophthalmologists did not diagnose with any eye conditions.

The positive effects are often reported after the first few applications, but I consider [low dose eye drops] a longer-term option. Due to the excellent diagnostic results and the complete absence of adverse effects from low dose drops (including results from ophthalmologists for a wide range of eye disorders) I increasingly view DMSO eye drops as a preventative measure, eye care for those with (still) healthy eyes, since modern life, particularly excessive screen time, places significant demands on our eyes.

Note: the above was extracted from an AI-generated summary of hundreds of hours of non-English lectures, then further condensed by me and hence not a direct quote (but one that accurately represents the author’s statements).

While this might be difficult to believe, consider a parallel situation. Another umbrella remedy I have been deeply impressed by, ultraviolet blood irradiation (which has many similar therapeutic properties to DMSO), has a vast volume of literature demonstrating its clinical value—including for numerous immensely challenging to treat diseases. Yet, virtually none of the medical profession even knows this therapy exists.

For this reason, we are currently sorting through thousands of UVBI studies, including dozens of studies (many of which were conducted with hundreds of patients) which show UVBI treats a myriad of challenging ophthalmologic conditions such as:

blepharitis,1 keratitis,1 corneal inflammation,1 herpes zoster ophthalmicus,1 traumatic eye infection,1 uveitis,1,2,3,4,5 iridocyclitis,1,2 choroiditis,1 chorioretinopathy,1,2,3,4 choroidal and chorioretinal dystrophy,1,2 macular degeneration,1 retinitis pigmentosa,1,2 retinal contusion,1 retinal ischemia,1,2 retinal and fundus hemorrhages,1,2,3,4 retinal artery and vein occlusions,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15 diabetic retinopathy,1 ischemic optic neuropathy,1,2,3,4,5 optic neuritis,1,2,3 optic nerve atrophy (traumatic or inflammatory),1,2,3 encephalopathic vision loss1

Note: in this article, each superscipt number links to either a reader’s story or an applicable study—like the many I listed above (which the ophthalmology profession does not realize exists).

As such, the purpose of this article will be to highlight exactly how DMSO is transforming ophthalmology, along with the supporting data.

The Forgotten Side of Medicine is a reader-supported publication.

To receive new posts and support my work, consider becoming a free or paid subscriber.

To learn more about this newsletter and how others have benefitted from it, click here!

Note: the best review paper on DMSO’s uses in ophthalmology (which is an excellent resource to provide to physicians who are skeptical of using DMSO for the eyes) can be read here.

Continue Reading

Health

For Anyone Planning on Getting or Mandating Others to Get an Influenza Vaccine (Flu Shot)

Published on

Injecting Freedom by Aaron Siri Aaron Siri

For anyone contemplating getting an influenza vaccine (flu shot) or planning to pressure or mandate someone else to get one:

meta-analysis of existing flu shot studies of healthy children by Cochrane (effectively owned by vaccine zealot Bill Gates) concluded that despite decades of published studies, it “could find no convincing evidence that [flu] vaccines can reduce mortality, hospital admissions, serious complications, or community transmission of influenza.”

Read that carefully: no convincing evidence—none—that flu shots lowered the chances of dying, being admitted to the hospital, suffering serious complications from the flu, or transmitting the flu to others.

In fact, studies have found those vaccinated for flu have a statistically significant increased rate of respiratory illnesses. Meaning, it increases the risk of having other respiratory illnesses.

For example, a placebo-controlled efficacy (not safety) study by researchers at the University of Hong Kong compared children receiving influenza vaccine with those who did not receive the vaccine. The study found no statistical difference in the rate of influenza between the groups but did find the vaccinated had a four times increased rate of non-influenza infections (“recipients had an increased risk of virologically confirmed non-influenza infections (relative risk: 4.40; 95% confidence interval: 1.31-14.8)”).

As another example, researchers at Columbia University found that the risk of “influenza in individuals during the 14-day post-vaccination period was similar to unvaccinated individuals during the same period (HR 0.96, 95% CI [0.60, 1.52])” but that the risk of “non-influenza respiratory pathogens was higher [in the vaccinated individuals] during the same period (HR 1.65, 95% CI [1.14, 2.38]).”

study by the Cleveland Clinic of 53,402 of its employees across multiple states even found an increased risk of influenza among those vaccinated for influenza, explaining that the “cumulative incidence of influenza was similar for the vaccinated and unvaccinated states early, but over the course of the study the cumulative incidence of influenza increased more rapidly among the vaccinated than the unvaccinated.”

From the Cleveland Clinic study.

I discuss these and other studies in my book, Vaccines, Amen.

That said: get a flu shot, don’t get a fu shot. That’s freedom. Everyone should be free to choose. But nobody should be coerced to get this or any medical product, especially, ironically, when the data reflects it has a net overall increase in infections.

If you do choose to get this product and are injured, you are always free to call our firm to represent you in the Vaccine Injury Compensation Program.

Injecting Freedom by Aaron Siri is a reader-supported publication.

To receive new posts and support my work, consider becoming a free or paid subscriber.

Aaron Siri, Managing Partner of Siri & Glimstad, has extensive complex civil litigation experience, including civil rights involving mandated medicine, class actions, and high stakes disputes. www.sirillp.com/aaron-siri/
Continue Reading

Trending

X